| ALL | Acute Lymphoblastic Leukemia |
| AML | Acute myeloid leukemia |
| ATF4 | transcription factor 4 |
| ATF6 | Activating Transcription Factor-6 |
| BCR | B-cell receptor |
| CHOP | C/EBP-homologous protein |
| CK1 | Casein kinase 1 |
| CK2 | Casein kinase 2 |
| CLL | Chronic Lymphocytic Leukemia |
| CMD | Chronic Myeloproliferative disorders |
| CML | Chronic Myeloid Leukemia |
| DEPTOR | DEP domain-containing mTOR-interacting protein |
| DLBCL | Diffuse large B-cell Lymphoma |
| Dvl | Dishevelled |
| eIF2α | eukaryotic translation initiation factor 2α |
| ER | Endoplasmic reticulum |
| FL | Follicular Lymphoma |
| FOXO3A | Forkhead Box O3 |
| Grp78/Bip | glucose regulated protein 78/Binding immunoglobulin protein |
| GSK3-β | Glycogen synthase kinase 3-β |
| Hsp90 | Heat Shock Protein 90 |
| IL-6 | Interleukin-6 |
| IRE1α | Inositol Requiring Enzyme 1 |
| JAK | Janus associated kinase-signal |
| LSCs | Leukemic-stem cells |
| MCL | Mantle Cell Lymphoma |
| MDM2 | Mouse Double Minute 2 |
| MDMX | Murine Double minute X |
| MDS | Myelodysplastic syndrome |
| MM | Multiple Myeloma |
| mTOR | Mammalian target of rapamycine |
| NF-kB | Nuclear Factor kappa-light-chain-enhancer of activated B cells |
| NHL | Non-Hodgkin Lymphoma |
| PDGFR | Platelet-derived growth factor receptors |
| PERK | PKR-like ER kinase |
| PI3K | Phosphoinositide 3-kinase |
| PIP3 | Phosphatidylinositol (3,4,5)-trisphosphate |
| PTEN | Phosphate and tensin homolog |
| PTM | Post translational modification |
| STAT3 | Signal transducer and activator of transcription 3 |
| UPR | Unfolded Protein response |